The Angelina Jolie effect – Impact on breast and ovarian cancer prevention A systematic review of effects after the public announcement in May 2013

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Health Education Journal

• Publication date

  2017-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0017896917712300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A Retrospective Exploration of the Impact of the ‘Angelina Jolie Effect’ on the Single State-Wide Familial Cancer Program in Perth, Western Australia

  2017influential reference
• Adoption of TSH Reflex algorithm in an Italian clinical laboratory.

  2017cited by this paper
• Factors that could influence women's participation in colorectal cancer screening: an Italian study.

  2017cited by this paper
• Can PSA Reflex Algorithm be a valid alternative to other PSA-based prostate cancer screening strategies?

  2017cited by this paper
• Legislation regulating availability of breast cancer treatment with particular focus on prophylactic mastectomy.

  2016influential reference
• Has the Angelina Jolie effect led to an increase in risk reducing mastectomy and breast reconstruction in Wales: A retrospective, single centre cohort study.

  2016cited by this paper
• Use of a systematic risk analysis method (FMECA) to improve quality in a clinical laboratory procedure.

  2016cited by this paper
• Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”

  2016cited by this paper
• Celebrity Health Announcements and Online Health Information Seeking: An Analysis of Angelina Jolie’s Preventative Health Decision

  2016influential reference
• Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”

  2016influential reference
• The Impact of Angelina Jolie (AJ)’s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada

  2016cited by this paper
• The Angelina effect revisited: Exploring a media‐related impact on public awareness

  2015influential reference
• The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers

  2015cited by this paper
• Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women

  2015cited by this paper
• Celebrity disclosures and information seeking: The case of Angelina Jolie

  2014influential reference
• Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.

  2014cited by this paper
• The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services

  2014influential reference
• Let the patient revolution begin

  2013cited by this paper
• Technologies for patient engagement.

  2013cited by this paper
• The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme

  2012cited by this paper
• Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.

  2011cited by this paper
• BRCA mutations in the management of breast cancer: the state of the art

  2010influential reference
• Inherited susceptibility to common cancers.

  2008cited by this paper
• Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

  2008cited by this paper
• Use of breast cancer screening and treatment services by Australian women aged 25-44 years following Kylie Minogue's breast cancer diagnosis.

  2008cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007influential reference
• No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

  2007cited by this paper
• Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer

  2006cited by this paper
• Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

  2004cited by this paper
• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

  2001influential reference
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

  1999cited by this paper

• Beyond BRCA: A scoping review of person-centred care for women diagnosed with a BRCA gene mutation

  2025cites this paper
• Awareness and knowledge of familial breast and ovarian cancer among German general practice patients

  2025influential citation
• A socially interdependent choice framework for social influences in healthcare decision-making: a study protocol

  2024cites this paper
• Google Trends–Assisted Analysis of the Readability, Accountability, and Accessibility of Online Patient Education Materials for the Treatment of AMD After US FDA Approval of Pegcetacoplan

  2024cites this paper
• Using online search activity for earlier detection of gynaecological malignancy

  2024cites this paper
• Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience

  2022cites this paper
• Miscarriage: a social networks users’ point of view

  2021cites this paper
• Psychiatric Aspects of Prophylactic Surgery in Adults

  2021cites this paper
• “I just re-evaluated what was beautiful when I went through treatment:” an analysis of Elly Mayday’s ovarian cancer narrative

  2021cites this paper
• The Power of Celebrity Health Events: Meta-analysis of the Relationship between Audience Involvement and Behavioral Intentions

  2020cites this paper
• Predicting Changes in Patient Choice of Preventive Health Care after Celebrity Diagnoses

  2020cites this paper
• The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer

  2020cites this paper
• Media coverage of calls to rename low-risk cancers: a content analysis

  2020cites this paper
• Whether, when, and how to communicate genetic risk to minors: ‘I wanted more information but I think they were scared I couldn’t handle it’

  2020cites this paper
• The impact of monthly campaigns and other high-profile media coverage on public interest in 13 malignancies: a Google Trends analysis

  2020cites this paper
• Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases

  2019cites this paper
• Language in the Provincial Capital Public Space in the Perspective of Local Wisdom

  2019cites this paper
• Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients

  2019cites this paper
• Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health care and medicine

  2019cites this paper
• Precision medicine / personalized medicine : a critical analysis of movements in the transformation of biomedicine in the early 21 st century

  2019cites this paper
• Investigating an Issue–Attention–Action Cycle: A Case Study on the Chronology of Media Attention, Public Attention, and Actual Vaccination Behavior during the 2019 Measles Outbreak in Austria

  2019cites this paper
• Associations Between Objective Television Exposure and Cancer Perceptions in a National Sample of Adults

  2019influential citation
• Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.

  2019cites this paper
• A patient-centered mobile health application to motivate use of genetic counseling among women with ovarian cancer: A pilot randomized controlled trial.

  2019cites this paper
• Communication about genetic testing and hereditary cancer management with breast and ovarian cancer patients

  2018cites this paper